Skip to content

Neuronetics STIM EPS (Basic)

EPS (Basic) at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
$0.04
LBR
LB Pharmaceuticals Inc Common StockLBRX
-$0.67+95.5%
CVRx, Inc. logo
CVRx, Inc.CVRX
-$0.50+5.7%
Stereotaxis logo
StereotaxisSTXS
-$0.06+14.3%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$0.20+4.8%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$1.97+2,363%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's EPS (basic)?
Neuronetics (STIM) reported EPS (basic) of -$0.16 in Q1 2026.
How has Neuronetics's EPS (basic) changed year-over-year?
Neuronetics's EPS (basic) increased by 23.8% year-over-year, from -$0.21 to -$0.16.
What is the long-term trend for Neuronetics's EPS (basic)?
Over 4 years (2021 to 2025), Neuronetics's EPS (basic) has grown at a -16.1% compound annual growth rate (CAGR), from -$1.19 to -$0.59.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.